Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

20.0%

2 terminated/withdrawn out of 10 trials

Success Rate

77.8%

-8.7% vs industry average

Late-Stage Pipeline

30%

3 trials in Phase 3/4

Results Transparency

0 of 7 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

3(42.9%)

Phase 3

3(42.9%)

Phase 1

1(14.3%)

7Total

N/A(3)

Phase 3(3)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT01863108Phase 1Completed

Safety Study of a Dendritic Cell-based Cancer Vaccine in Melanoma

Role: collaborator

NCT02114749Not ApplicableCompleted

Development of Tools for Respiration and Circulation Exploration

Role: collaborator

NCT01569503Phase 3Terminated

Vagus Nerve Stimulation a New Approach in the Treatment of Crohn's Disease

Role: collaborator

NCT03171571Not ApplicableCompleted

Personal Lifestyle Assistant for Better Health Through Nutrition

Role: collaborator

NCT02974530Unknown

Description and Modeling of Swallowing Disorders After a Stroke

Role: collaborator

NCT02317055Not ApplicableTerminated

Magnetic Resonance Imaging Evaluation of the Tissular Oxygen Saturation in Brain

Role: collaborator

NCT00838500Phase 3Completed

THERMES ET VEINES: Spa for Prevention of Leg Ulcers

Role: collaborator

NCT01258114Phase 3Completed

Maâthermes: Spa Treatment for Overweight and Obesity

Role: collaborator

NCT01106105Completed

Impact of Obesity on Postural Control

Role: lead

NCT01082432Completed

Electrical Stimulation to Recover Greater Range of Motion After Surgery

Role: lead

All 10 trials loaded